Navigation


The project











Newsroom







Affiliations
REACTION is affilliated with these programs and organisations:

Sign In

The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590


Newsletters
Read previous issues of our newsletter here:April 2014
August 2013
June 2012
August 2011
April 2011
November 2010
Most Read...
Articles
![]() |
186414 |
![]() |
112953 |
![]() |
105697 |
![]() |
105696 |
![]() |
79639 |
News
![]() |
57517 |
![]() |
53779 |
![]() |
51819 |
![]() |
49362 |
![]() |
47814 |
Popular Downloads
![]() |
30225 |
![]() |
13049 |
![]() |
11201 |
![]() |
10051 |
![]() |
6589 |
Research award for the GlucoTab
The GlucoTab won in the category 'commercial applications' for 'Human-Technology-Interface': Read more. The prize was a certificate and 7000 euroes.
The GlucoTab system was developed in REACTION as a workflow and insulin dosing support system for glycaemic management of hospitalised patients with diabetes.
It implements a novel, mobile, tablet-based workflow support system for nurses and physicians at the ward which includes a validated basal/bolus insulin titration protocol (REACTION algorithm) to provide decision support for daily glucose management of patients with diabetes.
In REACTION the GlucoTab system was validated in two clinical trials involving a total of 129 patients. Results show a decrease of the mean blood glucose, no increase of hypoglycaemic events and a high user acceptance. The GlucoTab system was CE marked in November 2013 and can now be used in a clinical routine.
The GlucoTab system was developed in REACTION as a workflow and insulin dosing support system for glycaemic management of hospitalised patients with diabetes.
It implements a novel, mobile, tablet-based workflow support system for nurses and physicians at the ward which includes a validated basal/bolus insulin titration protocol (REACTION algorithm) to provide decision support for daily glucose management of patients with diabetes.
In REACTION the GlucoTab system was validated in two clinical trials involving a total of 129 patients. Results show a decrease of the mean blood glucose, no increase of hypoglycaemic events and a high user acceptance. The GlucoTab system was CE marked in November 2013 and can now be used in a clinical routine.